Literature DB >> 815273

Human deficiency of the eighth component of complement. The requirement of C8 for serum Neisseria gonorrhoeae bactericidal activity.

B H Petersen, J A Graham, G F Brooks.   

Abstract

The serum of a 23-yr-old woman with prolonged disseminated gonococcal infection syndrome failed to normally promote hemolysis of sensitized sheep red blood cells (RBC). The patient's serum was deficient in the eight component of complement (C8) as determined by functional assays, immunoelectrophoresis, and quantitative immunoprecipitation. Functional titers of each of her other complement components were normal. No serum inhibitors of C8 were detected. The patient's serum supported activation of both the classical and alternate complement pathways. Her fresh serum lacked any bactericidal activity against Neisseria gonorrhoeae, but addition of purified C8 or complement donor serum restored bactericidal activity as well as RBC hemolytic activity. Her serum gave normal opsonization of yeast particles and staphylococci and had normal capacity to coat sensitized RBC with C8 and C4 and to generate chemotactic activity. No defects were observed in the patient's blood coagulation mechanisms. Complement-mediated bacterial lysis may be important in human defense against bacteremic Neisseria infections.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 815273      PMCID: PMC436652          DOI: 10.1172/JCI108279

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Bactericidal and opsonic properties of C4-deficient guinea pig serum.

Authors:  R K Root; L Ellman; M M Frank
Journal:  J Immunol       Date:  1972-09       Impact factor: 5.422

2.  Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3).

Authors:  C A Alper; N Abramson; R B Johnston; J H Jandl; F S Rosen
Journal:  N Engl J Med       Date:  1970-02-12       Impact factor: 91.245

3.  Increased susceptibility to infection in a patient with type II essential hypercatabolism of C3.

Authors:  C A Alper; K J Bloch; F S Rosen
Journal:  N Engl J Med       Date:  1973-03-22       Impact factor: 91.245

4.  Role of myeloperoxidase-mediated antimicrobial systems in intact leukocytes.

Authors:  S J Klebanoff; C B Hamon
Journal:  J Reticuloendothel Soc       Date:  1972-08

5.  Genetic aspects of diseases of complement: an explosion.

Authors:  M J Polley; A G Bearn
Journal:  Am J Med       Date:  1975-01       Impact factor: 4.965

6.  Studies on gonococcus infection. VI. Electron microscopic study on in vitro phagocytosis of gonococci by human leukocytes.

Authors:  J Swanson; B Zeligs
Journal:  Infect Immun       Date:  1974-09       Impact factor: 3.441

7.  Studies on gonococcus infection. V. Observations on in vitro interactions of gonococci and human neutrophils.

Authors:  J Swanson; E Sparks; B Zeligs; M A Siam; C Parrott
Journal:  Infect Immun       Date:  1974-09       Impact factor: 3.441

8.  Human heat labile opsonins: evidence for their mediation via the alternate pathway of complement activation.

Authors:  H E Jasin
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

9.  Studies on the virulence of Neisseria gonorrhoeae. I. Relation of colonial morphology and resistance to phagocytosis by polymorphonuclear leukocytes.

Authors:  C Thongthai; W D Sawyer
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

10.  Role of pili in the virulence of Neisseria gonorrhoeae.

Authors:  A P Punsalang; W D Sawyer
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

View more
  47 in total

1.  Plaque assay for measuring serum bactericidal activity against gonococci.

Authors:  L B Corbeil; A C Wunderlich; J I Ito; J A McCutchan
Journal:  J Clin Microbiol       Date:  1978-11       Impact factor: 5.948

Review 2.  Gonoccocal endocarditis.

Authors:  E C Thompson; D Brantley
Journal:  J Natl Med Assoc       Date:  1996-06       Impact factor: 1.798

3.  Absence of the eighth component of complement in association with systemic lupus erythematosus-like disease.

Authors:  H E Jasin
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

4.  Genetic polymorphism of human complement component C81 in the Japanese population.

Authors:  S Nakamura; O Ohue; K Abe
Journal:  Hum Genet       Date:  1986-04       Impact factor: 4.132

5.  Genetic polymorphism of complement component C8.

Authors:  S Rogde; B Mevåg; P Teisberg; T Gedde-Dahl; F Tedesco; B Olaisen
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

6.  Protective role of complement in experimental Escherichia coli endocarditis.

Authors:  D T Durack; P B Beeson
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

7.  Gonococci causing disseminated gonococcal infection are resistant to the bactericidal action of normal human sera.

Authors:  G K Schoolnik; T M Buchanan; K K Holmes
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

8.  Inherited deficiency of the seventh component of complement associated with nephritis. Propensity to formation of C56 and related C7-consuming activity.

Authors:  G R Nemerow; H Gewurz; S G Osofsky; T F Lint
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

9.  Two types of dysfunctional eighth component of complement (C8) molecules in C8 deficiency in man. Reconstitution of normal C8 from the mixture of two abnormal C8 molecules.

Authors:  F Tedesco; P Densen; M A Villa; B H Petersen; G Sirchia
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

10.  Genetic polymorphism in C8 beta-chains. Evidence for two unlinked genetic loci for the eighth component of human complement (C8).

Authors:  C A Alper; D Marcus; D Raum; B H Petersen; T J Spira
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.